The CBIS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CBIS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CBIS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CBIS Detailed Price Forecast - CNN Money||View CBIS Detailed Summary - Google Finance|
|View CBIS Detailed Summary - Yahoo! Finance||View CBIS Stock Research & Analysis - Zacks.com|
|View CBIS Trends & Analysis - Trade-Ideas||View CBIS Major Holders - Barrons|
|View CBIS Call Transcripts - NASDAQ||View CBIS Breaking News & Analysis - Seeking Alpha|
|View CBIS Annual Report - CompanySpotlight.com||View CBIS OTC Short Report - OTCShortReport.com|
|View CBIS Fundamentals - TradeKing||View CBIS SEC Filings - Bar Chart|
|View Historical Prices for CBIS - The WSJ||View Performance/Total Return for CBIS - Morningstar|
|View the Analyst Estimates for CBIS - MarketWatch||View the Earnings History for CBIS - CNBC|
|View the CBIS Earnings - StockMarketWatch||View CBIS Buy or Sell Recommendations - MacroAxis|
|View the CBIS Bullish Patterns - American Bulls||View CBIS Short Pain Metrics - ShortPainBot.com|
|View CBIS Stock Mentions - StockTwits||View CBIS Stock Mentions - PennyStockTweets|
|View CBIS Stock Mentions - Twitter||View CBIS Investment Forum News - Investor Hub|
|View CBIS Stock Mentions - Yahoo! Message Board||View CBIS Stock Mentions - Seeking Alpha|
|View Insider Transactions for CBIS - SECform4.com||View Insider Transactions for CBIS - Insider Cow|
|View CBIS Major Holdings Summary - CNBC||View Insider Disclosure for CBIS - OTC Markets|
|View Insider Transactions for CBIS - Yahoo! Finance||View Institutional Holdings for CBIS - NASDAQ|
|View CBIS Stock Insight & Charts - FinViz.com||View CBIS Investment Charts - StockCharts.com|
|View CBIS Stock Overview & Charts - BarChart||View CBIS User Generated Charts - Trading View|
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Posted on Friday September 06, 2019
IRVINE, CA, Sept. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that it is entering a transition stage as trading of the Company’s shares is halted. Cannabis Science will continue to implement its corporate growth strategy and intends to resolve all outstanding regulatory reporting and filing requirements as it goes through its transition. “I can confirm that I found out yesterday that the trading of Cannabis Science’s shares has been halted by regulatory authorities - clearly the paperwork states ‘due to the financials not being filed as a fully-reporting issuer’. While this is not a favorable situation, we are already addressing this matter directly with the authorities to protect the interests of our shareholders and stakeholders,” states Raymond C. Dabney, President, C.E.O. and Co-Founder of Cannabis Science.
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Posted on Tuesday August 27, 2019
IRVINE, CA, Aug. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has signed a joint venture agreement with a Canadian public company, NHS Industries, Ltd. NHS Industries (CSE: (NHS), (NNHHF)). The group will focus on job creation, deliver and develop public and private access educational content, and research various delivery platforms for medical cannabinoid-related products and services, all based on the CBIS Economic Development Plan for Canada, (CBIS/CDN EDP). The new Canadian-based partnership will expand Cannabis Science’s existing operations into Canada through its CDN EDP.
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Posted on Thursday August 15, 2019
IRVINE, CA, Aug. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is preparing to announce a number of exciting new partnerships and acquisitions as the Company prepares for a significant growth in revenue and positive cash flow from operations in key markets globally. The Company will be taking corporate actions to fast track this growth, including compiling the Company financials over the next quarter to achieve compliance with its fully reporting status requirements.
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
Posted on Monday August 05, 2019
IRVINE, CA, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has successfully completed reorganization of its European business to better align with the requirements of its customers, partners, and stakeholders. This move is expected to help improve the efficiency and effectiveness of CBIS’ European operations, and provide the necessary infrastructure to manage supply-chain logistics, new product development, and revenue growth. The Company’s activities, including cultivation, extraction, and manufacturing, will be headquartered in The Netherlands while all former Germany operations have been dissolved.